ETR:HNL Dr. Hönle (HNL) Stock Price, News & Analysis €7.52 +0.02 (+0.27%) (As of 12/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About Dr. Hönle Stock (ETR:HNL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dr. Hönle alerts:Sign Up Key Stats Today's Range€7.50▼€7.6650-Day Range€7.50▼€11.5552-Week Range€11.00▼€20.30Volume7,233 shsAverage VolumeN/AMarket Capitalization$45.57 millionP/E RatioN/ADividend Yield2.66%Price TargetN/AConsensus RatingN/A Company OverviewDr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.Read More… Receive HNL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter. Email Address HNL Stock News HeadlinesBest Hotels in Honolulu - Oahu, HI for 2024October 25, 2024 | travel.usnews.comDRHNF Dr. Hönle AGOctober 19, 2024 | seekingalpha.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.December 21, 2024 | Crypto Swap Profits (Ad)The past five years for Dr. Hönle (ETR:HNL) investors has not been profitableOctober 14, 2024 | finance.yahoo.comHNL Lab Medicine Announces Relocation of Allentown - AMC 17th Street Patient Service CenterOctober 4, 2024 | markets.businessinsider.comHNL Lab Medicine Relocates Route 61 Patient Service Center to Brunswick Business CenterSeptember 24, 2024 | markets.businessinsider.comTravel nurse fired amid Oahu nurse strike, lockoutSeptember 14, 2024 | msn.comUH Board of Regents name 2 finalists for next university presidentSeptember 12, 2024 | msn.comSee More Headlines HNL Stock Analysis - Frequently Asked Questions How have HNL shares performed this year? Dr. Hönle's stock was trading at €17.50 at the beginning of the year. Since then, HNL shares have decreased by 57.0% and is now trading at €7.52. View the best growth stocks for 2024 here. What other stocks do shareholders of Dr. Hönle own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Hönle investors own include D.R. Horton (DHI), Dr Pepper Snapple Group (DPS), Meta Platforms (META), MARA (MARA), Grayscale Future of Finance ETF (GFOF), BNY Mellon Strategic Municipal Bond Fund (DSM) and Dr. Ing. h.c. F. Porsche (DRPRF). Industry, Sector and Symbol Stock ExchangeETR SectorIndustrials Industry Electrical Equipment & Parts Sub-IndustryN/A Current SymbolETR:HNL CUSIPN/A CIKN/A Webwww.hoenle.de Phone49 89 85608 0FaxN/AEmployees581Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)(€0.91) Trailing P/E RatioN/A Forward P/E Ratio5.26 P/E Growth-0.39Net Income$-5,370,000.00 Net Margins-5.45% Pretax MarginN/A Return on Equity-5.51% Return on Assets4.56% Debt Debt-to-Equity Ratio59.06 Current Ratio1.98 Quick Ratio0.85 Sales & Book Value Annual Sales$98.69 million Price / Sales0.46 Cash Flow€0.38 per share Price / Cash Flow19.54 Book Value€15.43 per share Price / Book0.49Miscellaneous Outstanding Shares6,060,000Free FloatN/AMarket Cap$45.57 million OptionableNot Optionable Beta1.45 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (ETR:HNL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Hönle AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Hönle With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.